Literature DB >> 16488074

Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.

Hao Zhang1, Yuesheng Jin, Xuehua Chen, Charlotte Jin, Simon Law, Sai-Wah Tsao, Yok-Lam Kwong.   

Abstract

Infection with high-risk human papillomavirus (HPV) has been implicated in the pathogenesis of esophageal squamous cell carcinoma, and up-regulation of telomerase in esophageal adenocarcinoma. We immortalized normal esophageal epithelial cells by over-expression of the HPV16 E6/E7 and human telomerase reverse transcriptase (hTERT) genes. HPV16 E6/E7-induced immortalization was accompanied by reduced RB and p53, but increased p16 and p21, protein expression. hTERT-immortalized cells had unaffected RB and p53, but significantly decreased p16 and p21, protein expression. Aurora-A protein was also up-regulated in E6E7 immortalized cells, and to a less extent in hTERT immortalized cells. Fluorescence in situ hybridization showed that the Aurora-A gene locus was amplified in E6E7 immortalized cells, which might account in part for the Aurora-A over-expression. These molecular changes led to an abrogation of the G2 checkpoint. E6E7 and hTERT immortalized esophageal cells recapitulated many of the molecular changes observed in esophageal carcinomas, where RB and p53 are frequently down-regulated. However, down-regulation of p16 and p21 occurred frequently in esophageal cancer, owing to aberrant gene promoter methylation. We showed in the immortalized cells that aberrant methylation had not yet set in, suggesting that promoter methylation might not be necessary for cellular immortalization. In addition to supporting the role of HPV and telomerase in esophageal carcinogenesis, our cell lines may also be useful in vitro models for further studies of esophageal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488074     DOI: 10.1016/j.canlet.2006.01.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.

Authors:  Leo Studach; Wen-Horng Wang; Gregory Weber; Jiabin Tang; Ronald L Hullinger; Raphael Malbrue; Xiaoqi Liu; Ourania Andrisani
Journal:  J Biol Chem       Date:  2010-07-12       Impact factor: 5.157

2.  Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2011-11-16       Impact factor: 3.064

3.  Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition.

Authors:  Linda Vidarsdottir; Gudridur Steingrimsdottir; Sigridur Klara Bodvarsdottir; Helga Margret Ogmundsdottir; Jorunn Erla Eyfjord
Journal:  Invest New Drugs       Date:  2010-10-20       Impact factor: 3.850

Review 4.  Human papilloma virus (HPV) and host cellular interactions.

Authors:  Ioannis N Mammas; George Sourvinos; Athena Giannoudis; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

5.  Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis.

Authors:  Gordana Halec; Markus Schmitt; Sam Egger; Christian C Abnet; Chantal Babb; Sanford M Dawsey; Christa Flechtenmacher; Tarik Gheit; Martin Hale; Dana Holzinger; Reza Malekzadeh; Philip R Taylor; Massimo Tommasino; Margaret I Urban; Tim Waterboer; Michael Pawlita; Freddy Sitas
Journal:  Int J Cancer       Date:  2016-01-21       Impact factor: 7.396

6.  Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells.

Authors:  Christiane D Fichter; Corinna Herz; Claudia Münch; Oliver G Opitz; Martin Werner; Silke Lassmann
Journal:  BMC Cell Biol       Date:  2011-04-06       Impact factor: 4.241

7.  Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.

Authors:  Wen Wen Xu; Bin Li; Alfred K Y Lam; Sai Wah Tsao; Simon Y K Law; Kwok Wah Chan; Qiu Ju Yuan; Annie L M Cheung
Journal:  Oncotarget       Date:  2015-01-30

8.  Effects of HPV16E6 transfection on the biological behavior of Eca109 and Eca9706 cells.

Authors:  Xin-Dan Kang; Yong Zheng; Wei-Gang Chen; Min Cheng; Di Zhang
Journal:  Oncol Lett       Date:  2017-11-22       Impact factor: 2.967

9.  Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation.

Authors:  Lamech M Mwapagha; Nicki Tiffin; M Iqbal Parker
Journal:  Front Oncol       Date:  2017-11-01       Impact factor: 6.244

10.  Role of infectious agents in the carcinogenesis of brain and head and neck cancers.

Authors:  Kenneth Alibek; Ainur Kakpenova; Yeldar Baiken
Journal:  Infect Agent Cancer       Date:  2013-02-02       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.